Provitamin A: cleaved by BCMO1 in intestinal enterocytes into two retinal molecules, which are reduced to retinol. Conversion is regulated by vitamin A status — unlike preformed retinol, excess β-carotene does not accumulate as toxic retinoids. Also functions as a lipid-phase antioxidant and singlet-oxygen quencher.
Half-Life & Elimination Curve (PO: 37d)
Plasma (PO)t½ Decay (37d)
0×t½0h100%(14.1 µg/L)
1×t½37d50%(7.03 µg/L)
2×t½74d25%(3.52 µg/L)
3×t½111d12.5%(1.76 µg/L)
4×t½148d6.3%(0.879 µg/L)
5×t½185d3.1%(0.44 µg/L)
Elimination t½37d (PO)
Rate Constant (ke)0.000781 h⁻¹
Time to Peak (Tmax)19.9h
Est. Peak (Cmax)14.1 µg/L
Clearance (CL)0.0219 L/h
97% Washout (5×t½)185d
Dosing Guidelines
Oral (PO): Typical 4 mg (Range: 3–6 mg)
Pharmacokinetic Parameters
Oral (PO): Bioavailability (F): 10% · Volume of Distribution (Vd): 28 L · Absorption (ka): 0.3 h⁻¹ (t½ka ≈ 2.31h) [PMID 11481400]